SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS‐CoV‐2–host interactomes and provided great resources for understanding viral replica...

Full description

Bibliographic Details
Main Authors: Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, Taras Redchuk, Mariia Bogacheva, Kari Salokas, Ina Pöhner, Tiina Öhman, Arun Kumar Tonduru, Antti Hassinen, Lisa Gawriyski, Salla Keskitalo, Maria K Vartiainen, Vilja Pietiäinen, Antti Poso, Markku Varjosalo
Format: Article
Language:English
Published: Springer Nature 2021-11-01
Series:Molecular Systems Biology
Subjects:
drug discovery
mass spectrometry
proteomics
SARS‐CoV‐2
virus–host interactions
Online Access:https://doi.org/10.15252/msb.202110396

Internet

https://doi.org/10.15252/msb.202110396

Similar Items